1. Home
  2. MOLN vs ESOA Comparison

MOLN vs ESOA Comparison

Compare MOLN & ESOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOLN
  • ESOA
  • Stock Information
  • Founded
  • MOLN 2004
  • ESOA 2006
  • Country
  • MOLN Switzerland
  • ESOA United States
  • Employees
  • MOLN N/A
  • ESOA N/A
  • Industry
  • MOLN
  • ESOA Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • MOLN
  • ESOA Industrials
  • Exchange
  • MOLN Nasdaq
  • ESOA Nasdaq
  • Market Cap
  • MOLN 183.2M
  • ESOA 172.9M
  • IPO Year
  • MOLN 2021
  • ESOA 2006
  • Fundamental
  • Price
  • MOLN $3.81
  • ESOA $10.03
  • Analyst Decision
  • MOLN
  • ESOA Strong Buy
  • Analyst Count
  • MOLN 0
  • ESOA 1
  • Target Price
  • MOLN N/A
  • ESOA $21.00
  • AVG Volume (30 Days)
  • MOLN 3.2K
  • ESOA 286.7K
  • Earning Date
  • MOLN 05-15-2025
  • ESOA 05-12-2025
  • Dividend Yield
  • MOLN N/A
  • ESOA 0.30%
  • EPS Growth
  • MOLN N/A
  • ESOA 81.20
  • EPS
  • MOLN N/A
  • ESOA 1.09
  • Revenue
  • MOLN $2,525,030.00
  • ESOA $367,911,284.00
  • Revenue This Year
  • MOLN N/A
  • ESOA $9.95
  • Revenue Next Year
  • MOLN $866.67
  • ESOA N/A
  • P/E Ratio
  • MOLN N/A
  • ESOA $9.21
  • Revenue Growth
  • MOLN N/A
  • ESOA 4.62
  • 52 Week Low
  • MOLN $3.36
  • ESOA $6.50
  • 52 Week High
  • MOLN $12.70
  • ESOA $19.83
  • Technical
  • Relative Strength Index (RSI)
  • MOLN 46.07
  • ESOA 54.31
  • Support Level
  • MOLN $3.58
  • ESOA $9.77
  • Resistance Level
  • MOLN $4.11
  • ESOA $10.97
  • Average True Range (ATR)
  • MOLN 0.12
  • ESOA 0.72
  • MACD
  • MOLN -0.02
  • ESOA 0.10
  • Stochastic Oscillator
  • MOLN 33.74
  • ESOA 65.48

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

About ESOA Energy Services of America Corporation

Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is predominantly engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical, and automotive industries and does incidental work such as water and sewer projects. Energy Service's other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services, and other services related to pipeline construction.

Share on Social Networks: